Physician
Pathology Medical Group of Riverside
Pathology Medical Group of Riverside was paid $3.70M by Medicaid between Jan 2018 and Dec 2024, across 135 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 16% of everything it billed.
33Billing provider infoPATHOLOGY MEDICAL GROUP OF RIVERSIDE
RIVERSIDE, CA 92501
RIVERSIDE, CA 92501
33aNPI1417016833assigned 12/08/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$3.70M
24GClaims1,495,083
24DCodes billed135
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#12 of 222
Median peer was paid$42K
This provider vs. median87×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69,992 | $329K | |
| 2019 | 146,967 | $443K | |
| 2020 | 206,193 | $497K | |
| 2021 | 294,890 | $592K | |
| 2022 | 267,551 | $604K | |
| 2023 | 281,153 | $673K | |
| 2024incomplete | 228,337 | $560K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 16% | 11,412 | 10,854 | $601K |
| 88307 | 9.2% | 4,651 | 4,538 | $340K | |
| 80053 | Comprehensive metabolic panel | 8.9% | 164,620 | 95,948 | $328K |
| 85027 | 8.1% | 258,523 | 126,209 | $298K | |
| 88312 | 5.0% | 5,484 | 5,195 | $185K | |
| 83735 | 3.3% | 91,773 | 27,262 | $123K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.2% | 75,558 | 35,263 | $117K |
| 84484 | 2.8% | 48,321 | 40,595 | $102K | |
| 83690 | 2.4% | 70,570 | 60,292 | $87K | |
| 83880 | 2.3% | 14,486 | 13,123 | $84K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 25,312 | 23,769 | $79K |
| 88304 | 2.0% | 3,156 | 3,122 | $75K |
123 more codes
| 84100 | 1.9% | 79,407 | $70K | |
| 88313 | 1.6% | 1,720 | $59K | |
| 83605 | 1.5% | 28,968 | $57K | |
| 87040 | 1.5% | 17,492 | $54K | |
| 84703 | 1.2% | 36,006 | $46K | |
| 87150 | 1.2% | 1,034 | $43K | |
| 85730 | 1.1% | 33,362 | $41K | |
| 83498 | 1.1% | 8,829 | $41K | |
| 87631 | 1.1% | 3,196 | $40K | |
| 88341 | 1.1% | 667 | $40K | |
| 88342 | <1% | 1,027 | $36K | |
| 83789 | <1% | 9,090 | $30K | |
| 81001 | <1% | 49,914 | $29K | |
| 82261 | <1% | 10,697 | $29K | |
| 80074 | <1% | 3,688 | $28K | |
| 85610 | <1% | 36,029 | $27K | |
| 80061 | Lipid panel | <1% | 11,759 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,638 | $26K |
| 82803 | <1% | 8,357 | $25K | |
| 88108 | <1% | 1,425 | $25K | |
| 83020 | <1% | 11,062 | $24K | |
| 86140 | <1% | 25,866 | $23K | |
| 82140 | <1% | 8,420 | $21K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,706 | $21K |
| 84702 | <1% | 7,484 | $20K | |
| 86900 | <1% | 36,224 | $19K | |
| 86901 | <1% | 37,118 | $19K | |
| 83516 | <1% | 10,625 | $18K | |
| 80202 | <1% | 6,242 | $18K | |
| 82776 | <1% | 10,485 | $16K | |
| 87186 | <1% | 7,650 | $15K | |
| 88302 | <1% | 472 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,069 | $13K |
| 86850 | <1% | 24,292 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,065 | $13K |
| 87070 | <1% | 6,965 | $12K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 732 | $12K |
| 82150 | <1% | 10,381 | $12K | |
| 85379 | <1% | 6,536 | $12K | |
| 87077 | <1% | 5,297 | $11K | |
| 82728 | <1% | 4,338 | $10K | |
| 85652 | <1% | 20,281 | $9K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,276 | $9K |
| 84439 | <1% | 5,284 | $8K | |
| 82248 | <1% | 9,413 | $8K | |
| 80076 | <1% | 6,070 | $8K | |
| 82746 | <1% | 3,445 | $8K | |
| 85384 | <1% | 4,737 | $8K | |
| 83615 | <1% | 6,791 | $7K | |
| 82247 | <1% | 9,031 | $7K | |
| 82607 | <1% | 2,745 | $6K | |
| 82550 | <1% | 4,548 | $6K | |
| 86780 | <1% | 2,651 | $6K | |
| 86880 | <1% | 5,637 | $5K | |
| 87205 | <1% | 5,979 | $5K | |
| 84145 | <1% | 1,069 | $5K | |
| 87088 | <1% | 3,430 | $5K | |
| 83550 | <1% | 2,660 | $4K | |
| 83540 | <1% | 2,905 | $4K | |
| 87483 | <1% | 51 | $3K | |
| 87075 | <1% | 1,425 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,884 | $3K |
| 82570 | <1% | 3,066 | $3K | |
| 84550 | <1% | 4,002 | $3K | |
| 88311 | <1% | 523 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 745 | $2K |
| 87899 | <1% | 2,199 | $2K | |
| 82010 | <1% | 1,467 | $2K | |
| 87340 | <1% | 1,287 | $2K | |
| 84134 | <1% | 872 | $2K | |
| 88300 | <1% | 359 | $2K | |
| 82565 | <1% | 1,926 | $2K | |
| 87210 | <1% | 1,586 | $2K | |
| 84156 | <1% | 2,639 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 328 | $1K |
| 85014 | <1% | 2,716 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $1K |
| 87449 | <1% | 684 | $1K | |
| 87102 | <1% | 697 | $1K | |
| 85018 | <1% | 2,455 | $1K | |
| 85049 | <1% | 1,324 | $1K | |
| 87116 | <1% | 509 | $1K | |
| 82553 | <1% | 385 | $961.82 | |
| 87015 | <1% | 525 | $709.11 | |
| 84300 | <1% | 738 | $651.91 | |
| 86870 | <1% | 198 | $650.79 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 369 | $564.71 |
| 88360 | <1% | 12 | $486.32 | |
| 85045 | <1% | 689 | $462.90 | |
| 89051 | <1% | 84 | $384.20 | |
| 81003 | <1% | 635 | $379.72 | |
| 84478 | <1% | 389 | $368.25 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 213 | $349.89 |
| 86480 | <1% | 30 | $348.69 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 25 | $339.20 |
| 84436 | <1% | 146 | $230.00 | |
| 87800 | <1% | 56 | $166.48 | |
| 87486 | <1% | 20 | $151.07 | |
| 86038 | <1% | 72 | $144.89 | |
| 86317 | <1% | 58 | $125.63 | |
| 80164 | <1% | 46 | $119.46 | |
| 86631 | <1% | 57 | $118.84 | |
| 87581 | <1% | 15 | $116.77 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $113.55 |
| 86632 | <1% | 30 | $65.67 | |
| 87106 | <1% | 30 | $56.08 | |
| 86704 | <1% | 27 | $51.10 | |
| 89050 | <1% | 13 | $50.58 | |
| 86635 | <1% | 16 | $42.63 | |
| 86762 | <1% | 14 | $37.97 | |
| 82040 | <1% | 42 | $37.28 | |
| 86738 | <1% | 15 | $31.52 | |
| 87324 | <1% | 13 | $27.84 | |
| 84132 | <1% | 25 | $22.52 | |
| 86592 | <1% | 32 | $22.00 | |
| 87081 | <1% | 17 | $21.45 | |
| 85461 | <1% | 25 | $20.50 | |
| 82272 | <1% | 14 | $17.78 | |
| 83930 | <1% | 17 | $17.28 | |
| 82945 | <1% | 24 | $17.13 | |
| 83935 | <1% | 15 | $15.24 | |
| 84157 | <1% | 13 | $10.65 | |
| 84133 | <1% | 13 | $8.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOKADA, DARREN (OWNER - MEDICAL DIRECTOR)